(Q41248237)

English

Immune reactions induced by interleukin-2 transfected colorectal cancer cells in vitro: predominant induction of lymphokine-activated killer cells

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Immune reactions induced by interleukin-2 transfected colorectal cancer cells in vitro: predominant induction of lymphokine-activated killer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

author name string

M Lindauer

1

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

H K Schackert

2

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

J Gebert

3

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

W Rudy

4

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

A Habicht

5

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

M Siebels

6

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

S C Meuer

7

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

U Moebius

8

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Journal of Molecular Medicine

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

74

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

43-49

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

The immunobiological effects of interleukin-2 in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulated expression of foreign genes in mammalian cells under the control of coliphage T3 RNA polymerase and lac repressor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of stable cytolytic T-cell clones directed against autologous human melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental and clinical studies of cytokine gene-modified tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive ability

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte response

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of tumor-specific cytotoxic T lymphocytes and natural killer cells by tumor cells transfected with the interleukin-2 gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble HLA-A2.1 restricted peptides that are recognized by influenza virus specific cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of immunogenic colorectal cancer cell lines for vaccination: expression of CD80 (B7.1) is not sufficient to restore impaired primary T cell activation in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of cytolytic effector cell response in vitro against autologous human tumor cells genetically altered to synthesize interleukin-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer cells and the MHC class I pathway of peptide presentation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8834769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00202071

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41248237&oldid=2204412818"